The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
| Pharmaceuticals Industry | Healthcare Sector | Tiewei Song CEO | OTC PINK Exchange | 05552Q301 CUSIP |
| US Country | 296 Employees | - Last Dividend | 16 Sep 2010 Last Split | 18 Oct 2006 IPO Date |
BIMI Holdings Inc., initially established in 2000 and headquartered in New York, New York, operates through its subsidiaries to engage significantly in the retail and wholesale distribution sector for medical devices, along with pharmaceutical and other healthcare products within the People's Republic of China. The company strategizes its operations across four primary segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. Historically known as BIMI International Medical Inc., the company underwent a rebranding to BIMI Holdings Inc. in January 2024, reflecting a broader scope of operations. Besides retail and wholesale distribution, BIMI Holdings Inc. extends its services to managing two private hospitals in China and offers IT research and development services, showcasing a comprehensive integration within the healthcare industry and technological advancements.
BIMI Holdings Inc. distributes a wide array of products including, but not limited to, Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment. These products find their clientele mainly among drug stores, private clinics, pharmaceutical dealers, and hospitals located in the Southwest region of China. Additionally, the company's vast wholesale distribution network encompasses various pharmaceutical products ranging from raw ingredients for manufacturing to ready-to-use medicines such as antibiotics, cardiovascular drugs, and anti-obesity medicines.
Under the Lijiantang Pharmacy brand, BIMI Holdings offers an extensive selection of pharmaceutical and healthcare products directly to consumers. Their product range includes prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, and personal and family care products. The retail pharmacies segment also features a diverse variety of medical devices and miscellaneous items, catering to a broad spectrum of health and wellness needs.
BIMI Holdings extends its portfolio into the healthcare sector by operating two private hospitals in China. These institutions provide a range of medical services, ensuring high-quality healthcare and support for various medical needs within their communities. The company's involvement in medical services underscores its commitment to enhancing healthcare access and quality in the regions it serves.
Apart from its core operations in the healthcare and pharmaceutical sectors, BIMI Holdings Inc. acknowledges the importance of technology in modern healthcare practices. Through its IT research and development services, the company aims to contribute to the technological advancements within the healthcare industry, emphasizing the development of software and hardware solutions that can improve medical services and operations efficiency.